Altium Capital Management LP Legend Biotech Corp Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
80.2MCall Options Held
237KPut Options Held
366K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$406 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$273 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$242 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$208 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$208 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.09B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...